BTLA Antikörper (AA 170-220)
Kurzübersicht für BTLA Antikörper (AA 170-220) (ABIN6991902)
Target
Alle BTLA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 170-220
-
Spezifität
- BTLA antibody is human specific. At least two isoforms of BTLA are known to exist.
-
Aufreinigung
- BTLA Antibody is affinity chromatography purified via peptide column.
-
Immunogen
- BTLA antibody was raised against a 17 amino acid peptide near the center of human BTLA. The immunogen is located within amino acids 170 - 220 of BTLA .
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
BTLA antibody can be used for detection of BTLA by Western blot at 1 - 2 μ,g/mL.
Antibody validated: Western Blot in human samples, Immunohistochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- BTLA Antibody is supplied in PBS containing 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,4 °C
-
Informationen zur Lagerung
- BTLA antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
-
-
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Andere Bezeichnung
- BTLA
-
Hintergrund
- The B- and T-lymphocyte attenuator (BTLA) protein is a member of the immunoglobulin superfamily containing a single immunoglobulin (Ig) domain (1). Like other coihibitory receptors such as CTLA-4 and PD-1, BTLA functions as a receptor that relays inhibitory signals to suppress the immune response, and can inhibit LPS-induced endotoxic shock by suppressing TLR4 signaling in innate immune cells (1,2). Polymorphisms in this gene have also been associated with an increased risk of rheumatoid arthritis (3).
-
Molekulargewicht
-
Predicted: 32 kDa
Observed: 40kDa -
Gen-ID
- 151888
-
NCBI Accession
- NP_861445
-
UniProt
- Q7Z6A9
-
Pathways
- Cancer Immune Checkpoints
Target
-